Bliss GVS Pharma Limited has informed the Exchange regarding allotment of 75250 securities pursuant to ESOP/ESPS at its meeting held on Jun 06, 2025
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma has allotted 75,250 equity shares to eligible employees who exercised their stock options under the Bliss GVS ESOP-2019 plan. The shares have a face value of Re. 1 each and were issued at an exercise price of Rs. 43 per share (premium of Rs. 42). As a result, the company's paid-up share capital has increased from 10,53,70,273 to 10,54,45,522 equity shares, a marginal rise of about 0.07%. The newly allotted shares carry a 6-month lock-in period from the date of allotment, expiring on December 6, 2025, and will rank equally with existing equity shares once listed.
This is a minor dilution event with negligible impact on shareholding structure, and reflects the company incentivising employees. Shareholders should note that 75,250 shares will come out of lock-in on December 6, 2025, though the small size means any supply pressure on the stock is likely insignificant.